WEE1 and cancer: Moreover, future preclinical and clinical studies may continue to investigate the translational potential of WEE1 inhibitor for cancer patients carrying SETD8C302R, e.g., by using genetically modified animal models or conducting retrospective analysis on results from clinical trials of WEE1 inhibitors.